Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mahfoud

Showing results (371-380 of 614) with videos related to

Pageof 62
Sort By:
ESC Heart Failure|May 18, 2021
Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapiesAna Jorbenadze, Marat Fudim, Felix Mahfoud, et al.
Circulation|October 2, 2024
Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-AnalysisDavor Vukadinović, Lucas Lauder, David E Kandzari, et al.
American Journal of Hypertension|July 16, 2014
Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervationDominik Linz, Mathias Hohl, Jonathan Schütze, et al.
Hypertension (Dallas, Tex. : 1979)|February 27, 2026
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and MortalityLucas Lauder, Igor Schwantke, Alejandro de la Sierra, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trialsRoland E Schmieder, Douglas A Hettrick, Michael Böhm, et al.
European Journal of Heart Failure|March 13, 2026
Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantationFelix Götzinger, Thorald Stolte, Jakob Reichl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 27, 2015
Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervationOliver Dörr, Sebastian Ewen, Christoph Liebetrau, et al.
Hypertension (Dallas, Tex. : 1979)|September 28, 2020
Confounding Factors in Renal Denervation Trials: Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for HypertensionDavid E Kandzari, Felix Mahfoud, Deepak L Bhatt, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 20, 2025
Sex stratified analysis of patients with resistant hypertension from the Global SYMPLICITY Registry of renal denervationAnastasia S Mihailidou, Felix Mahfoud, Markus Schlaich, et al.
Pageof 62

Showing results (371-380 of 614) with videos related to

Sort By:
Pageof 62
ESC Heart Failure|May 18, 2021
Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapiesAna Jorbenadze, Marat Fudim, Felix Mahfoud, et al.
Circulation|October 2, 2024
Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-AnalysisDavor Vukadinović, Lucas Lauder, David E Kandzari, et al.
American Journal of Hypertension|July 16, 2014
Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervationDominik Linz, Mathias Hohl, Jonathan Schütze, et al.
Hypertension (Dallas, Tex. : 1979)|February 27, 2026
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and MortalityLucas Lauder, Igor Schwantke, Alejandro de la Sierra, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trialsRoland E Schmieder, Douglas A Hettrick, Michael Böhm, et al.
European Journal of Heart Failure|March 13, 2026
Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantationFelix Götzinger, Thorald Stolte, Jakob Reichl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 27, 2015
Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervationOliver Dörr, Sebastian Ewen, Christoph Liebetrau, et al.
Hypertension (Dallas, Tex. : 1979)|September 28, 2020
Confounding Factors in Renal Denervation Trials: Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for HypertensionDavid E Kandzari, Felix Mahfoud, Deepak L Bhatt, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 20, 2025
Sex stratified analysis of patients with resistant hypertension from the Global SYMPLICITY Registry of renal denervationAnastasia S Mihailidou, Felix Mahfoud, Markus Schlaich, et al.
Pageof 62